Summary
The amyloid protein precursor (APP) is cleaved in its intramembranous domain by γ-secrease to generate amyloid β and a free carboxyl-terminal intracellular fragment. The carboxyl-terminal of 105 amino acids of APP (APP-C105) plays a crucial role in the neuropathology of Alzheimer’s disease (AD), but it is incompletely understand how APP-C105 overexpression interacts and regulates the brain function and Aβ-42 levels, and whether or not it is associated with the expressions of GSK3β-binding proteins. To test this, transgenic mice expressing NSE-controlled APP-C105 were produced and tested for their above phenotypes. A behavioral deficit was observed in the 9 months old transgenic mice, and western blot indicated that there was a predominant expression of APP-C105 in transgenic brains compared with those of non-transgenic brains. In parallel, APP-C105 overexpression resulted in the modulation of the Aβ-42 level, γ-secretase activity, GSK3β-binding proteins including PS1, tau, and β-catenin in the brains of the transgenic mice relative to the non-transgenic mice. Thus, altered expressions of these neuropathological phenotypes in APP-C105 transgenic mice could be useful targets in developing new therapeutic treatments.
Similar content being viewed by others
References
Abe, K., and Saito, H. (2000). Amyloid Β neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured and hippocampal and cortical neurons. Neurosci. Lett. 292:1–4.
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., and van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neurotic plaques in the cerebral cortex of patient with Alzheimer’s disease. Cereb. Cortex 1:103–106.
Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., Guida, T., Hu, K., Hung, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguten, M., Soriano, F., Vasquenz, N., Weiss, K., Welch, B., Seuber, P., Schenk, D., and Yednock, T. (2000). Peripherally administered antibodies agonist amyloid Β-peptide enter the nervous system and reduce pathology in a mouse model of Alzheimer’s disease. Nat. Med. 6:916–919.
Cassone, A., Conti, S., Bernards, F.D., and Polonelli, L. (1997). Antibodies, killer toxins and antifungal immunoprecipitation: A lesson fromnature? Immunol. Today 18:164–169.
Choi, S.H., Park, C.H., Koo, J.W., Seo, J.H., Kim, H.S., Jeong, S.J., Lee, J.H., Kim, S.S., and Suh, Y.H. (2001). Memory impairment and cholinergic dysfunction by centrally administered Abeta and carboxyl-terminal fragment of Alzheimer’s APP in mice. FASEB J. 15:1816–1818.
Citron, M., Diehl, T., S., Gordon, G., Biere, A.L., Seubert, P., and Selkoe, D. J. (1996). Evidence that the 42- and 40-amino acid forms of amyloid Β protein are generated from the Β-amyloid precussor protein by different protease activities. Proc. Natl. Acad. Sci. U.S.A. 93:3170–13175.
Conti, S., Magliani, W., Gerloni, M., Salati, A., Dieci, E., Arseni, S., Fisicaro, P., and Polonelli, L. (1998). A transphyletic anti-infectious control strategy based on the killer phenomenon. FEMS Immunol. Med. Microbiol. 22:151–161.
Doble, B.W., and Woodgett, J.R. (2003). GSK3Β: Tricks of the trade for a multi-tasking kinase. J. Cell. Sci. 116:1175–1186.
Downward, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10:262–267.
Fitzpatrick, J.L., Mize, A.L., Wade, C.B., Harris, J.A., Shapiro, J.L., and Dorsa, D.M. (2002). Estrogen-mediated neuroprotection against Β-amyloid toxicity requires expression of estrogen receptor Α or Β and activation of the MAPK pathway. J. Neurochem. 82: 674–682.
Forss-Petter, S., Denielson, P.E., Catsicas, S., Battenberg, E., Price, J., Nerenberg, M., and Sutcliffe, M. (1990). Transgenic mice expressing Β-galactosidase in mature neuron under neuron-specific enolase promoter control. Cell. 5:187–197.
Gervais, F.G., Robertson, G.S., Vaillancourt, J.P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M.S., Clarke, E.E., Zheng, H., van Der. Ploeg, L.H., Ruffolo, S.C., Thrnberry, N.A., Xanthoudakis, S., Zamboni, R.J., Roy, S., and Nicolson, D.W. (1999). Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-Β precusor protein and amyloidogenic AΒ peptide formation. Cell 97: 395–406.
Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., and Selkoe, D.E. (1992). Amyloid-peptide is produced by cultured cells during normal metabolism. Nature 359:32–35.
Haass, C., and Stropper, B. (1999). The presenilin in Alzheimer’s disease-proteolysis hold the key. Science 286:916–919.
Hwang, D.Y., Chae, K.R., Kang, T.S., Hwang, J.H., Lim, C.H., Kang, H.K., Goo, J.S., Lee, M.R., Lim, H.J., Min, S.H., Cho, J.Y., Hong, J.T., Song, C.W., Paik, S.G., Cho, J.S., and Kim, Y.K. (2002). Alterations in behavior, amyloid Β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer’s disease. FASEB J. 16:805–813.
Hwang, D.Y., Cho, J.S., Lee, S.H., Chae, K.R., Lim, H.J., Min, S.H., Seo, S.J., Song, Y.S., Song, C.W., Paik, S.G., Sheen, Y.Y., and Kim, Y.K. (2004). Aberrant expressions of pathogenic phenotypes in Alzheimer’s diseased transgenic mice carrying NSE-controlled APPsw. Exp. Neurol. 86:20– 32.
Ida, N., Hartmann, T., Pantel, J., Schroeder, J., Zerfass, R., Foerstel, H., Sandbrink, R., Masters, C. L., and Beyreuther, K. (1996). Analysis of heterogeneous ΒA42 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271:22908–22914.
Ishigura, K., Omori, A., Takematsu, M., Sato, K., Arioka, M., Uchida, T., and Imahori, K. (1992). Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148:202–206.
Ishgura, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Ukida, T., and Imahori, K. (1993). Glycogen synthase kinase 3Β is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 325:167–172.
Johnson, S.A., Rogers, J., and Finch, C.E. (1989). APP695 transcript prevalence is selectively reduced during Alzheimer’s disease in cortex and hippocampus but not in cellebellum. Neurobiol. Aging 10:7557–7560.
Kammesheidt, A., Boice, F.M., Spanoyannis, A.F., Cumming, B.J., Ortegon, M., Cotman, C., Vaught, J.L., and Neve, R.L. (1992). Deposition of Β/A4 immunoreactivity and neuronal pathway in transgenic mice expressing the carboxyl terminal fragment of the Alzheimer amyloid precursor in the brain. Proc. Natl. Acad. Sci. U.S.A. 89:10857–10861.
Kirschenbaum, F., Hsu, S.C., Cordell, B., and McCarthy, J.V. (2001) Glycogen synthase kinase-3Β regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276:30701–30707.
Klafuki, H., Abramowski, D., Swoboda, R., Paganetti, P.A., and Staufenbiel, M. (1996). The carboxyl-termini of Β amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities J. Biol. Chem. 271:28655–28659.
Liu, Z., Gastard, M., Verina, T., Bora, S., Mouton, P.R., and Koliatsos, V.E. (2001). Estrogens modulate experimentally induced apoptosis of granule cells in the adult hippocampus. J. Comp. Neurol. 44: 1–8.
Lovestone, S., Reynolds, C.H., Latimer, D., Davis, D.R., Anderton, B.H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J.R., and Miller, C. (1994). Alzheimer’s disease like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1077–1086.
Lucas, J.J., Hermandez, F., Gomez-Ramos, P., Moran, M.A., Hen, R., and Avila, J. (2001). Decreased nuclear Β-catenin, tau hyperphosphorylation and neurodegeration in GSK-3Β conditional transgenic mice. EMBO J. 20:27–39.
Manthey, D., Heck, S., and Behi, C. (2001). Estrogen induces a rapid secretion of amyloid Β precusor protein via mitogen-activated protein kinas pathway. Eur. J. Biochem. 268:4285–4291.
McDonnell, D.P., Chang, C.Y., and Norris, J.D. (2001). Capitalizing the complexities of estrogen receptors pharmacology in the quest for the perfect SERM. Ann. N.Y. Acad. Sci. 949:16–35.
McKenna, N.J., and O’Malley, B.W. (2001). Nuclear receptor, coregulator, ligands, and selective receptor modulators: Making sense of the patch work guilt. Ann. NY. Acad. Sci. 949:3–5.
Means, A.R., Comstock, J.P., Rosenfield, G.C., and O’Malley, B.W. (1972). Ovalbumin messenger RNA of chick oviduct partial charaterization, estrogen dependence, and translation in vitro. Proc. Natl. Acad. Sci. U.S.A. 69:1146–1150.
Murphy, M.P., Hickman, L.J., Eckman, C.B., Uljon, S.N., Wang, R., and Golde, T.E. (1999). γ-Secreatse, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid Β-peptide of varying length. J. Biol. Chem. 274:11914–11923.
Nalbantoglu, J., Tirado-Santiago, G., Lahsaini, A., Poirier, J., Goncalves, O., Verge, G., Momoli, F., Welner, S.A., Massicotte, G., Julien, J.P., and Shapiro, M.L. (1997). Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 29:387(632), 500–505.
Oster-Granite, M.L., McPhie, D.L., Greenan, J., and Neve, R.L. (1996). Age-dependent neuronal and synaptic degeration in mice transgenic for the C Terminus of the amyloid precursor protein. J.Neurosci. 16:6732–6741.
Paech, K., Webb, P., Kuiper, G.G.J.M., Nilson, S., Gustafson, J.A., Kushner, P.J., and Scanlan, T.S. (1997). Differential ligand activation of estrogen receptors ERΑ and ERΒ at AP1 site. Science 277:1508–1510.
Phiel, C.J., Wilson, C.A., Lee, V. M.-Y., and Klein, P.S. (2003). GSKΑ regulates production of AD amyloid-Β peptides. Nature 4223:435–429
Sato, M., Kawarabayashi, T., Shoji, M., Kobayashi, T., Tada, N., Matsubara, E., and Hiraim, S.M. (1997). Neurogeneration and gliosis in transgenic mice overexpressing a carboxyl-terminal fragment of Alzheimer amyloid-Β protein precursor. Dement. Geriatr. Cognit. Disorders 8:296–307.
Schenk, D., Barbour, R., Dunn, W., Gorden, G., Grajeda, H., Guido, T., Hu, K., Hung, J., Jhnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg. I., Matter, R., Mutter, L., Soriano, F., Shopp, G., Vasquenz, N., Vandevert, C., Walker, S., Wogulis, M., Yednoclk, T., Games, D., and Seubert, P. (1999). Immunization with amyloid Β attenuates Alzheimer’s disease-like pathology in the PDAAP mouse. Nature 400:173–177.
Sun, X., Sato, S., Murayama, O., Murayama, M., Park, J.M., Yamaguchi, H., and Takashima, A. (2002). Lithium inhibits amyloid secretion in COS cells transfected with amyloid precursor protein C100. Neurosci. Lett. 321:61–64.
Takashima, A., Honda, T., Yasutake, K., Michael, G., Murayama, O., Murayama, M., Ishiguro, K., and Yamaguchi, H. (1998A). Activation of tau protein kinase I and glycogen synthase kinase-3Β by amyloid Β peptide (25–35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31:317–323.
Takeshima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Merken, M., Yamaguchi, H., Sugihara, S., and Wolozin, B. (1998B). Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. 95:9637–9641.
Tesco, G., and Tanzi, R.E. (2000). GSK3Β forms a tetrameric complex with endogenous PS1-CTF/NTF and Β-catenin. Ann. New. York. Acad. Sci. 920:227–232.
Vogt, B. A., Crino, P. B., and Vogt, L. J. (1992). Recrganization of cinglulate cortex I Alzheimer’s disease: neuron loss, neuritic plaques, and muscarinic receptor binding. Cereb. Cortex 2:526–535.
Wei, W., Norton, D.D., Wang, X., and Kusiak, J.W. (2002). AΒ 17–42 in Alzheimer’s disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain 125:2036–2043
West, M. J. (1994).Differences in the pattern of hippocampal neuron loss in normal ageing andAlzheimer’s disease. Lancet 344:526–535.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, H.J., Cho, J.S., Oh, J.H. et al. NSE-Controlled Carboxyl-Terminus of APP Gene Over-Expressing in Transgenic Mice Induces Altered Expressions in Behavior, Aβ-42, and GSK3β Binding Proteins. Cell Mol Neurobiol 25, 833–850 (2005). https://doi.org/10.1007/s10571-005-4937-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10571-005-4937-7